-
公开(公告)号:US20240190909A1
公开(公告)日:2024-06-13
申请号:US18511231
申请日:2023-11-16
Applicant: H. Lundbeck A/S
Inventor: Klaus Gjervig Jensen , Lisbet Kværnø , Morten Jørgensen , Martin Juhl , Heidi Lopez De Diego , Karin Fredholt , Frans Dennis Therkelsen , Tobias Gylling Frihed , Mikkel Fog Jacobsen
IPC: C07H15/26
CPC classification number: C07H15/26 , C07B2200/13
Abstract: The present invention relates to new solid forms of the compound (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid with the formula (Id) below.
The compound of formula (Id) is a prodrug of a catecholamine for use in treatment of neurodegenerative diseases and disorders such as Parkinson's Disease.-
公开(公告)号:US11858954B2
公开(公告)日:2024-01-02
申请号:US17392970
申请日:2021-08-03
Applicant: H. Lundbeck A/S
Inventor: Klaus Gjervig Jensen , Lisbet Kværnø , Morten Jørgensen , Martin Juhl , Heidi Lopez de Diego , Karin Fredholt , Frans Dennis Therkelsen , Tobias Gylling Frihed , Mikkel Fog Jacobsen
IPC: C07H15/26
CPC classification number: C07H15/26 , C07B2200/13
Abstract: The present invention relates to new solid forms of the compound (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid with the formula (Id) below.
The compound of formula (Id) is a prodrug of a catecholamine for use in treatment of neurodegenerative diseases and disorders such as Parkinson's Disease.-
公开(公告)号:US20220024962A1
公开(公告)日:2022-01-27
申请号:US17392970
申请日:2021-08-03
Applicant: H. Lundbeck A/S
Inventor: Klaus Gjervig Jensen , Lisbet Kværnø , Morten Jørgensen , Martin Juhl , Heidi Lopez de Diego , Karin Fredholt , Frans Dennis Therkelsen , Tobias Gylling Frihed , Mikkel Fogh Jacobsen
IPC: C07H15/26
Abstract: The present invention relates to new solid forms of the compound (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid with the formula (Id) below. The compound of formula (Id) is a prodrug of a catecholamine for use in treatment of neurodegenerative diseases and disorders such as Parkinson's Disease.
-
公开(公告)号:US11130775B2
公开(公告)日:2021-09-28
申请号:US16876908
申请日:2020-05-18
Applicant: H. Lundbeck A/S
Inventor: Klaus Gjervig Jensen , Lisbet Kværnø , Morten Jørgensen , Martin Juhl , Heidi Lopez de Diego , Karin Fredholt , Frans Dennis Therkelsen , Tobias Gylling Frihed , Mikkel Fog Jacobsen
IPC: C07H15/26
Abstract: The present invention relates to new solid forms of the compound (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid with the formula (Id) below. The compound of formula (Id) is a prodrug of a catecholamine for use in treatment of neurodegenerative diseases and disorders such as Parkinson's Disease.
-
-
-